Eva Kolwijck

2.0k total citations
55 papers, 1.2k citations indexed

About

Eva Kolwijck is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Eva Kolwijck has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Infectious Diseases and 14 papers in Surgery. Recurrent topics in Eva Kolwijck's work include Pneumonia and Respiratory Infections (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Urinary Tract Infections Management (7 papers). Eva Kolwijck is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Urinary Tract Infections Management (7 papers). Eva Kolwijck collaborates with scholars based in Netherlands, United States and South Africa. Eva Kolwijck's co-authors include Frank L. van de Veerdonk, Leon F.A.G. Massuger, Jinlong Shao, John A. Jansen, Fang Yang, Heiman Wertheim, Jiankang Song, Sander C.G. Leeuwenburgh, Jaap ten Oever and Paul E. Verweij and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Eva Kolwijck

55 papers receiving 1.2k citations

Peers

Countries citing papers authored by Eva Kolwijck

Since Specialization

Citations

This map shows the geographic impact of Eva Kolwijck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kolwijck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kolwijck more than expected).

Fields of papers citing papers by Eva Kolwijck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kolwijck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kolwijck. The network helps show where Eva Kolwijck may publish in the future.

Co-authorship network of co-authors of Eva Kolwijck

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kolwijck. A scholar is included among the top collaborators of Eva Kolwijck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kolwijck. Eva Kolwijck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital 2025 ·Influenza and Other Respiratory Viruses ·Koos Korsten, Matthijs R. A. Welkers, Thijs van de Laar, Alex Wagemakers, Peter van Hengel, Peter C. Wever, Eva Kolwijck	2
2	Using the Sysmex UF‐4000 urine flow cytometer for rapid diagnosis of urinary tract infection in the clinical microbiological laboratory 2024 ·Journal of Clinical Laboratory Analysis ·Koos Korsten, (unknown), Alexander C. A. P. Leenders, Peter C. Wever, Eva Kolwijck	3
3	Cost Effectiveness of Rectal Culture-based Antibiotic Prophylaxis in Transrectal Prostate Biopsy: The Results from a Randomized, Nonblinded, Multicenter Trial 2023 ·European Urology Open Science ·(unknown), Eva Kolwijck, Evert L. Koldewijn, Diederik M. Somford, (unknown), (unknown), A.J. Breeuwsma, (unknown), (unknown), Rob A. Schipper, Martijn G. Steffens, Marjolijn Wegdam-Blans, (unknown), Wouter van den Bijllaardt, Alexander C. A. P. Leenders, J.P. Michiel Sedelaar, Heiman Wertheim, Eddy Adang	2
4	An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients 2022 ·Clinical Pharmacokinetics ·(unknown), Rob ter Heine, Jeroen Schouten, J. A. M. Raaijmakers, Jaap ten Oever, Eva Kolwijck, David M. Burger, Peter Pickkers, Tim Frenzel, Roger J. M. Brüggemann	11
5	First Case of Human Brucella canis Infection in the Netherlands 2022 ·Clinical Infectious Diseases ·Eva Kolwijck, Suzanne P. M. Lutgens, (unknown), (unknown), (unknown), Ad P. Koets, (unknown), Frans A.G. Reubsaet, Els M. Broens, Laetitia M. Kortbeek	9
6	Genome-wide analysis in Escherichia coli unravels a high level of genetic homoplasy associated with cefotaxime resistance 2021 ·Microbial Genomics ·Jordy P. M. Coolen, (unknown), Jaco J. Verweij, Jodie A. Schildkraut, Kornelia Neveling, Willem J. G. Melchers, Eva Kolwijck, Heiman Wertheim, Jan Kluytmans, Martijn A. Huynen	7
7	Validation and implementation of the Panbio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers 2021 ·Infection Prevention in Practice ·Eva Kolwijck, (unknown), (unknown), (unknown), (unknown), Adam Meijer, M. H. A. Hermans, Alexander C. A. P. Leenders	9
8	Epidemiology and Clinical Management of Fusarium keratitis in the Netherlands, 2005–2016 2020 ·Frontiers in Cellular and Infection Microbiology ·Claudy Oliveira dos Santos, Eva Kolwijck, Frank J.A. van Rooij, (unknown), Nienke Visser, Yanny Y.Y. Cheng, (unknown), Paul E. Verweij, Cathrien A. Eggink	32
9	Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study 2019 ·BMC Infectious Diseases ·Eva Kolwijck, (unknown), (unknown), Antoine G. van der Heijden, J.P. Michiel Sedelaar, Jaap ten Oever	15
10	Quantification of viable bacterial load in artificial sputum spiked with Mycobacterium tuberculosis 2019 ·Tuberculosis ·Sven O. Friedrich, Eva Kolwijck, (unknown), Lize van der Merwe, Andreas H. Diacon	1
11	Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality 2018 ·Journal of Critical Care ·(unknown), Rebecca M. Koch, D. van Beuningen, (unknown), Frank L. van de Veerdonk, Eva Kolwijck, Johannes G. van der Hoeven, D. C. J. J. Bergmans, Cornelia Hoedemaekers	89
12	Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study 2018 ·PLoS ONE ·Erik J. van Lindert, (unknown), Michiel van der Flier, Eva Kolwijck, Hans Delye, Jaap ten Oever	18
13	Microbiological and immunological characteristics of a lethal pulmonary Aspergillus niger infection in a non-neutropenic patient 2018 ·Medical Mycology Case Reports ·(unknown), (unknown), Mark S. Gresnigt, Katharina L. Becker, Peter Pickkers, Frank L. van de Veerdonk, Yvonne F. Heijdra, Eva Kolwijck	5
14	Reduced rate of intensive care unit acquired gram-negative bacilli after removal of sinks and introduction of ‘water-free’ patient care 2017 ·Antimicrobial Resistance and Infection Control ·Joost Hopman, Alma Tostmann, Heiman Wertheim, (unknown), Eva Kolwijck, Reinier Akkermans, Patrick Sturm, Andreas Voß, Peter Pickkers, (unknown)	85
15	Animal models for percutaneous-device-related infections: a review 2017 ·International Journal of Antimicrobial Agents ·Jinlong Shao, Eva Kolwijck, John A. Jansen, Fang Yang, X. Frank Walboomers	7
16	The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer 2010 ·European Journal of Clinical Investigation ·Eva Kolwijck, Janko Kos, Nataša Obermajer, Paul N. Span, Chris M.G. Thomas, Leon F.A.G. Massuger, Fred C.G.J. Sweep	26
17	Prevalence of cysts in epithelial ovarian cancer 2010 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Eva Kolwijck, (unknown), Johan Bulten, Jos H.A. Vollebergh, Ron A. Wevers, Leon F.A.G. Massuger	7
18	Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors 2009 ·Journal of Cancer Research and Clinical Oncology ·Eva Kolwijck, Leon F.A.G. Massuger, Chris M.G. Thomas, Paul N. Span, Marta Krašovec, Janko Kos, Fred C.G.J. Sweep	23
19	A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis 2007 ·Gynecologic Oncology ·Anne M. van Altena, (unknown), Eva Kolwijck, Joanne A. de Hullu, Leon F.A.G. Massuger	10
20	Stage IV epithelial ovarian carcinoma in an 18 year old patient presenting with a Sister Mary Joseph's nodule and metastasis in both breasts: A case report and review of the literature 2007 ·Gynecologic Oncology ·Eva Kolwijck, Erik A. Boss, Anne M. van Altena, L.V.A.M. Beex, Leon F.A.G. Massuger	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact